Slinda Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Like with other hormonal contraceptives changes in the bleeding pattern was an adverse event frequently reported in the clinical trials (see Pharmacology: Pharmacodynamics under Actions).
The most commonly reported adverse reactions in long-term clinical trials of more than 9 cycles of treatment with drospirenone (2,700 women) were acne (3.8%), metrorrhagia (2.9%), headache (2.7%) and breast pain (2.2%).
Tabulated list of adverse reactions: Adverse reactions that have been reported in short- and long-term clinical trials with Slinda are listed in the table as follows.
All adverse reactions are listed by system organ class and frequency: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000). (See table.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Slinda Adverse Reactions

Manufacturer:

Exeltis

Distributor:

DKLL